Happy to share our most recent clinical trial data, supporting efficacy and safety of a third vaccine dose in immunosuppressed patients who did not seroconvert upon regular vaccination.
https://t.co/oVxaHm0DE2
Very happy to share our most recent results on the vaccination efficacy against SARS-CoV-2 in Rituximab treated patients, thanks to all collaborators !!!
https://t.co/C7om9qPICD
Excited to share our most recent findings
SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response https://t.co/CJUzQkuEgr
Unusually harsh words even from @EuroBriefing and I’m afraid he’s right.
If government leaders don’t trust the science, trust in vaccination is gone. If we don’t rely on @EMA_News, ANY common EU approach is doomed.
Governments, don’t politicise and prevaricate, vaccinate !